Pharaoh Neuro

Pharaoh Neuro has developed a novel device to remove blood and blood-borne toxins from the cerebrospinal fluid in patients suffering from subarachnoid hemorrhage and other CSF-related pathologies.

www.pharaohneuro.com
Minneapolis, MN

CEO: Amaza Reitmeier
Arboretum Lead: Jeff Terrell

IN THE NEWS
July 27, 2026 in Home Page, News Page, Pharaoh Neuro

HistoSonics CEO Mike Blue joins Pharaoh Neuro Board of Directors

Pharaoh Neuro recently announced the addition of HistoSonics Chair and CEO Mike Blue to its board of directors.
Read More
February 20, 2026 in Home Page, News Page, Pharaoh Neuro

Pharaoh Neuro Secures $20 Million Series A and Appoints CEO and CMO to Advance Neurapheresis™ Platform

Pharaoh Neuro, Inc., a medical device company developing innovative solutions for neurocritical care, today announced the closing of an oversubscribed $20 million Series A financing and the appointments of Amaza…
Read More